September 2023
1. FU Z, Xu C, Gao L
   Dual potential embolic source detected in left atrium during hyperacute stroke.
   Heart. 2023;109:1449-1498.
   

   >> Share

   
   
2. AKERSTROM F, Hutter J, Charitakis E, Tabrizi F, et al
   Association between catheter ablation of atrial fibrillation and mortality or stroke.
   Heart. 2023 Sep 1:heartjnl-2023-322883. doi: 10.1136/heartjnl-2023-322883.
   

   >> Share

   
   August 2023
3. KERR AJ, Choi Y, Williams MJ, Stewart RA, et al
   Paired risk scores to predict ischaemic and bleeding risk twenty-eight days to one year after an acute coronary syndrome.
   Heart. 2023 Aug 9:heartjnl-2023-322830. doi: 10.1136/heartjnl-2023-322830.
   

   >> Share

   
   July 2023
4. ANDRADE JG, Deyell MW, Bennett R, Macle L, et al
   Assessment and management of asymptomatic atrial fibrillation.
   Heart. 2023 Jul 28:heartjnl-2023-322428. doi: 10.1136/heartjnl-2023-322428.
   

   >> Share

   
   
5. TRIVEDI R, Marschner S, Shaw T, Min H, et al
   Factors influencing blood pressure control in patients with atrial fibrillation and hypertension in Australian primary care.
   Heart. 2023 Jul 20:heartjnl-2023-322602. doi: 10.1136/heartjnl-2023-322602.
   

   >> Share

   
   
6. PARSONS RE, Liu X, Collister JA, Clifton DA, et al
   Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank.
   Heart. 2023 Jul 9:heartjnl-2022-321231. doi: 10.1136/heartjnl-2022-321231.
   

   >> Share

   
   
7. HOHMANN C, Pfister R, Frerker C, Beckmann A, et al
   Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation.
   Heart. 2023 Jul 5:heartjnl-2023-322548. doi: 10.1136/heartjnl-2023-322548.
   

   >> Share

   
   June 2023
8. CAI H, Chen G, Hu W, Jiang C, et al
   Anticoagulant in atrial fibrillation patients with prior intracranial haemorrhage: a meta-analysis.
   Heart. 2023 Jun 15:heartjnl-2023-322492. doi: 10.1136/heartjnl-2023-322492.
   

   >> Share

   
   May 2023
9. DAGENAIS GR, Pais P, Gao P, Roshandel G, et al
   Fixed dose combination therapies in primary cardiovascular disease prevention in different groups: an individual participant meta-analysis.
   Heart. 2023 May 31:heartjnl-2022-322278. doi: 10.1136/heartjnl-2022-322278.
   

   >> Share

   
   April 2023
10. RAO S, Nazarzadeh M, Li Y, Canoy D, et al
    Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk.
    Heart. 2023 Apr 20:heartjnl-2023-322431. doi: 10.1136/heartjnl-2023-322431.
    

    >> Share

    
    
11. RAISI-ESTABRAGH Z, Cooper J, McCracken C, Crosbie EJ, et al
    Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer.
    Heart. 2023 Apr 18:heartjnl-2022-321888. doi: 10.1136/heartjnl-2022-321888.
    

    >> Share

    
    March 2023
12. PAUSCH J, Harmel E, Reichenspurner H, Kempfert J, et al
    Subannular repair in secondary mitral regurgitation with restricted leaflet motion during systole.
    Heart. 2023 Mar 27:heartjnl-2022-322239. doi: 10.1136/heartjnl-2022-322239.
    

    >> Share

    
    
13. AHN HJ, Lee SR, Choi EK, Lee SW, et al
    Metabolic syndrome and ischaemic stroke in non-anticoagulated atrial fibrillation with low CHA(2)DS(2)-VASc scores.
    Heart. 2023 Mar 24:heartjnl-2022-322143. doi: 10.1136/heartjnl-2022-322143.
    

    >> Share

    
    
14. BEYER SE, Secemsky EA, Khabbaz K, Carroll BJ, et al
    Elective ascending aortic aneurysm repair outcomes in a nationwide US cohort.
    Heart. 2023 Mar 16:heartjnl-2022-322033. doi: 10.1136/heartjnl-2022-322033.
    

    >> Share

    
    
15. PANT A, Gribbin S, McIntyre D, Trivedi R, et al
    Primary prevention of cardiovascular disease in women with a Mediterranean diet: systematic review and meta-analysis.
    Heart. 2023 Mar 14:heartjnl-2022-321930. doi: 10.1136/heartjnl-2022-321930.
    

    >> Share

    
    
16. ROBIJN AL, Filion KB, Woodward M, Hsu B, et al
    Comparative effect of varenicline and nicotine patches on preventing repeat cardiovascular events.
    Heart. 2023 Mar 6:heartjnl-2022-322170. doi: 10.1136/heartjnl-2022-322170.
    

    >> Share

    
    
17. FINK T, Sciacca V, Sommer P
    Catheter ablation of atrial fibrillation after percutaneous left atrial appendage closure: friend or foe?
    Heart. 2023 Mar 1:heartjnl-2023-322374. doi: 10.1136/heartjnl-2023-322374.
    

    >> Share

    
    February 2023
18. MCCORMICK A, Krishnan A, Badesch D, Benza RL, et al
    Pulmonary artery compliance in different forms of pulmonary hypertension.
    Heart. 2023 Feb 14:heartjnl-2022-321760. doi: 10.1136/heartjnl-2022-321760.
    

    >> Share

    
    
19. NORHAMMAR A, Bodegard J, Vanderheyden M, Tangri N, et al
    Prevalence, outcomes and costs of a contemporary, multinational population with heart failure.
    Heart. 2023 Feb 13:heartjnl-2022-321702. doi: 10.1136/heartjnl-2022-321702.
    

    >> Share

    
    
20. NADARAJAH R, Wu J, Hogg D, Raveendra K, et al
    Prediction of short-term atrial fibrillation risk using primary care electronic health records.
    Heart. 2023 Feb 9:heartjnl-2022-322076. doi: 10.1136/heartjnl-2022-322076.
    

    >> Share

    
    
21. CHEN JJ, Chiu FC, Chang SN, Cheng HL, et al
    Impact of pre-existing left atrial appendage occluder on catheter ablation of atrial fibrillation.
    Heart. 2023 Feb 7:heartjnl-2022-321934. doi: 10.1136/heartjnl-2022-321934.
    

    >> Share

    
    
22. ROUTLEDGE H, Curzen N
    Percutaneous management of acute ischaemic stroke.
    Heart. 2023 Feb 3:heartjnl-2022-321604. doi: 10.1136/heartjnl-2022-321604.
    

    >> Share

    
    January 2023
23. JOY M, Williams J, Emanuel S, Kar D, et al
    Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014-2019).
    Heart. 2023;109:195-201.
    

    >> Share

    
    
24. LINZ D, Schnabel RB
    Gut microbiota-derived metabolites in atrial fibrillation: risk markers or modifiable risk factors?
    Heart. 2023 Jan 2:heartjnl-2022-321806. doi: 10.1136/heartjnl-2022-321806.
    

    >> Share

    
    
25. LUCIANI M, Muller D, Vanetta C, Diteepeng T, et al
    Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation.
    Heart. 2023 Jan 2:heartjnl-2022-321300. doi: 10.1136/heartjnl-2022-321300.
    

    >> Share

    
    December 2022
26. BULARGA A, Newby DE, Chapman AR
    Not to be sneezed at: cardiovascular disease after COVID-19 infection.
    Heart. 2022;109:84-85.
    

    >> Share

    
    November 2022
27. GUPTA D, Ding WY, Calvert P, Williams E, et al
    Cryoballoon Pulmonary Vein Isolation as First-Line Treatment for Typical Atrial Flutter.
    Heart. 2022 Nov 17. pii: heartjnl-2022-321729. doi: 10.1136/heartjnl-2022-321729
    

    >> Share

    
    
28. RAISI-ESTABRAGH Z, Cooper J, Bethell MS, McCracken C, et al
    Lower birth weight is linked to poorer cardiovascular health in middle-aged population-based adults.
    Heart. 2022 Nov 16. pii: heartjnl-2022-321733. doi: 10.1136/heartjnl-2022-321733
    

    >> Share

    
    
29. ANDERSEN MJ, Wolsk E, Bakkestrom R, Christensen N, et al
    Pressure-flow responses to exercise in aortic stenosis, mitral regurgitation and diastolic dysfunction.
    Heart. 2022;108:1895-1903.
    

    >> Share

    
    October 2022
30. CASO V, de Groot JR, Sanmartin Fernandez M, Segura T, et al
    Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2022 Oct 31. pii: heartjnl-2022-321114. doi: 10.1136/heartjnl-2022-321114
    

    >> Share

    
    
31. RAISI-ESTABRAGH Z, Cooper J, Salih A, Raman B, et al
    Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank.
    Heart. 2022 Oct 24. pii: heartjnl-2022-321492. doi: 10.1136/heartjnl-2022-321492
    

    >> Share

    
    
32. THALMANN I, Preiss D, Schlackow I, Gray A, et al
    Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009-2017.
    Heart. 2022 Oct 3. pii: heartjnl-2022-321452. doi: 10.1136/heartjnl-2022-321452.
    

    >> Share

    
    July 2022
33. KANY S, Cardoso VR, Bravo L, Williams JA, et al
    Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank.
    Heart. 2022 Jul 14. pii: heartjnl-2022-321196. doi: 10.1136/heartjnl-2022-321196
    

    >> Share

    
    
34. KIM HJ, Chang DH, Kim SO, Kim JK, et al
    Left atrial appendage preservation versus closure during surgical ablation of atrial fibrillation.
    Heart. 2022 Jul 13. pii: heartjnl-2022-320939. doi: 10.1136/heartjnl-2022-320939
    

    >> Share

    
    June 2022
35. MARROQUIN L, Tirado-Conte G, Pracon R, Streb W, et al
    Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure.
    Heart. 2022;108:1098-1106.
    

    >> Share

    
    April 2022
36. KOMEN J, Pottegard A, Hjemdahl P, Mantel-Teeuwisse AK, et al
    Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds.
    Heart. 2022;108:613-618.
    

    >> Share

    
    
37. MORITA S, Malik AH, Kuno T, Ando T, et al
    Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.
    Heart. 2022;108:606-612.
    

    >> Share

    
    
38. HOLT A, Blanche P, Zareini B, Rasmussen PV, et al
    Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants.
    Heart. 2022;108:626-632.
    

    >> Share

    
    March 2022
39. RAATIKAINEN P, Lassila R
    COVID-19: another reason for anticoagulation in patients with atrial fibrillation.
    Heart. 2022 Mar 21. pii: heartjnl-2022-320845. doi: 10.1136/heartjnl-2022-320845
    

    >> Share

    
    
40. HANDY A, Banerjee A, Wood AM, Dale C, et al
    Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort.
    Heart. 2022 Mar 10. pii: heartjnl-2021-320325. doi: 10.1136/heartjnl-2021-320325
    

    >> Share

    
    
41. BARBIELLINI AMIDEI C, Trevisan C, Dotto M, Ferroni E, et al
    Association of physical activity trajectories with major cardiovascular diseases in elderly people.
    Heart. 2022;108:360-366.
    

    >> Share

    
    
42. WANG X, Dong JY, Cui R, Muraki I, et al
    Smoking cessation, weight gain and risk of cardiovascular disease.
    Heart. 2022;108:375-381.
    

    >> Share

    
    February 2022
43. EVERS-DORPFELD S, Aeschbacher S, Hennings E, Eken C, et al
    Sex-specific differences in adverse outcome events among patients with atrial fibrillation.
    Heart. 2022 Feb 8. pii: heartjnl-2021-320122. doi: 10.1136/heartjnl-2021-320122.
    

    >> Share

    
    
44. OTTO CM
    Heartbeat: bleeding risk in atrial fibrillation patients on non-vitamin K oral anticoagulant medications.
    Heart. 2022;108:243-245.
    

    >> Share

    
    January 2022
45. OTTO CM
    Heartbeat: sex disparities in stroke, heart failure and all-cause mortality in adults with coronary heart disease.
    Heart. 2022;108:1-3.
    

    >> Share

    
    December 2021
46. OTTO CM
    Heartbeat: lower risk of dementia with a direct oral anticoagulatant, compared to a vitamin K antagonist, for patients with atrial fibrillation.
    Heart. 2021;107:1847-1849.
    

    >> Share

    
    
47. FRAISSE A, Hascoet S, Kempny A
    Closing atrial septal defects for prevention of stroke: how small is too small?
    Heart. 2021;107:1850-1851.
    

    >> Share

    
    
48. DOLGNER SJ, Steinberg ZL, Jones TK, Reisman M, et al
    Stroke in patients with secundum atrial septal defect and sequelae after transcatheter closure.
    Heart. 2021;107:1875-1880.
    

    >> Share

    
    October 2021
49. CADOGAN SL, Powell E, Wing K, Wong AY, et al
    Anticoagulant prescribing for atrial fibrillation and risk of incident dementia.
    Heart. 2021 Oct 13. pii: heartjnl-2021-319672. doi: 10.1136/heartjnl-2021-319672
    

    >> Share

    
    
50. NADARAJAH R, Alsaeed E, Hurdus B, Aktaa S, et al
    Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis.
    Heart. 2021 Oct 4. pii: heartjnl-2021-320036. doi: 10.1136/heartjnl-2021-320036.
    

    >> Share

    
    
51. ARORA GK, Kumar Gupta P, Bansal S
    Transient ischaemic attack in a young woman.
    Heart. 2021;107:1629-1682.
    

    >> Share

    
    September 2021
52. BARNETT-GRINESS O, Stein N, Kotler A, Saliba W, et al
    Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants.
    Heart. 2021 Sep 21. pii: heartjnl-2021-319702. doi: 10.1136/heartjnl-2021-319702
    

    >> Share

    
    August 2021
53. AKYEA RK, Kontopantelis E, Kai J, Weng SF, et al
    Sex disparity in subsequent outcomes in survivors of coronary heart disease.
    Heart. 2021 Aug 24. pii: heartjnl-2021-319566. doi: 10.1136/heartjnl-2021-319566
    

    >> Share

    
    
54. SCHNABEL RB, Wallenhorst C, Engler D, Blankenberg S, et al
    Refined atrial fibrillation screening and cost-effectiveness in the German population.
    Heart. 2021 Aug 10. pii: heartjnl-2020-318882. doi: 10.1136/heartjnl-2020-318882
    

    >> Share

    
    July 2021
55. FUKAYA H, Ako J, Yasuda S, Kaikita K, et al
    Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319321. doi: 10.1136/heartjnl-2021-319321
    

    >> Share

    
    
56. PHILLIPS K, Subramanian A, Thomas GN, Khan N, et al
    Trends in the pharmacological management of atrial fibrillation in UK general practice 2008-2018.
    Heart. 2021 Jul 5. pii: heartjnl-2021-319338. doi: 10.1136/heartjnl-2021-319338.
    

    >> Share

    
    June 2021
57. PARKER WA, Storey RF
    Antithrombotic therapy for patients with chronic coronary syndromes.
    Heart. 2021;107:925-933.
    

    >> Share

    
    
58. TAM DY, Rocha RV, Fang J, Ouzounian M, et al
    Multiple arterial coronary bypass grafting is associated with greater survival in women.
    Heart. 2021;107:888-894.
    

    >> Share

    
    May 2021
59. DAGENAIS GR, Dyal L, Bosch JJ, Leong DP, et al
    Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.
    Heart. 2021 May 21. pii: heartjnl-2020-318758. doi: 10.1136/heartjnl-2020-318758
    

    >> Share

    
    
60. ELVAN A
    It's all about improvement of quality of life and reduction of disease burden in atrial fibrillation ablation.
    Heart. 2021 May 20. pii: heartjnl-2021-319382. doi: 10.1136/heartjnl-2021-319382
    

    >> Share

    
    
61. CHOI Y, Lee Y, Kim SH, Kim S, et al
    Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.
    Heart. 2021 May 14. pii: heartjnl-2020-318750. doi: 10.1136/heartjnl-2020-318750
    

    >> Share

    
    
62. RUTHERFORD OW, Jonasson C, Ghanima W, Soderdahl F, et al
    Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation.
    Heart. 2021 May 11. pii: heartjnl-2020-318753. doi: 10.1136/heartjnl-2020-318753
    

    >> Share

    
    
63. PARK J, Yoon YE, Kim KM, Hwang IC, et al
    Prognostic value of lower bone mineral density in predicting adverse cardiovascular disease in Asian women.
    Heart. 2021 May 7. pii: heartjnl-2020-318764. doi: 10.1136/heartjnl-2020-318764.
    

    >> Share

    
    
64. JOLOBE O
    Next frontier is inclusion of high-grade carotid artery stenosis in the CHA2DS2 Vasc score.
    Heart. 2021;107:767.
    

    >> Share

    
    
65. KARTHIKEYAN G
    Stroke risk in rheumatic heart disease.
    Heart. 2021;107:694-696.
    

    >> Share

    
    April 2021
66. BUCHAN TA, Malik A, Chan C, Chambers J, et al
    Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses.
    Heart. 2021 Apr 8. pii: heartjnl-2021-319243. doi: 10.1136/heartjnl-2021-319243.
    

    >> Share

    
    
67. SPARROW R, Sanjoy S, Choi YH, Elgendy IY, et al
    Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure.
    Heart. 2021 Apr 1. pii: heartjnl-2020-318650. doi: 10.1136/heartjnl-2020-318650.
    

    >> Share

    
    
68. SCOTT ML, Murnane KS, Orr AW
    Young at heart? Drugs of abuse cause early-onset cardiovascular disease in the young.
    Heart. 2021;107:604-606.
    

    >> Share

    
    
69. GEURINK K, Holmes D, Ezekowitz MD, Pieper K, et al
    Patterns of oral anticoagulation use with cardioversion in clinical practice.
    Heart. 2021;107:642-649.
    

    >> Share

    
    March 2021
70. MELDUNI R, Nkomo VT, Wysokinski W, Gersh BJ, et al
    Risk of left atrial appendage thrombus and stroke in patients with atrial fibrillation and mitral regurgitation.
    Heart. 2021 Mar 25. pii: heartjnl-2020-317659. doi: 10.1136/heartjnl-2020-317659
    

    >> Share

    
    
71. VENETSANOS D, Traff E, Erlinge D, Hagstrom E, et al
    Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention.
    Heart. 2021 Mar 12. pii: heartjnl-2020-318694. doi: 10.1136/heartjnl-2020-318694
    

    >> Share

    
    February 2021
72. LOWRES N, Giskes K, Freedman B
    Next frontier in management of atrial fibrillation.
    Heart. 2021 Feb 23. pii: heartjnl-2021-318961. doi: 10.1136/heartjnl-2021-318961
    

    >> Share

    
    January 2021
73. BOSSARD M, Gao P, Boden W, Steg G, et al
    Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease.
    Heart. 2021 Jan 27. pii: heartjnl-2020-318045. doi: 10.1136/heartjnl-2020-318045
    

    >> Share

    
    
74. MALLINSON PAC, Luhar S, Williamson E, Barreto ML, et al
    Socioeconomic position and cardiovascular mortality in 63 million adults from Brazil.
    Heart. 2021 Jan 22. pii: heartjnl-2020-318153. doi: 10.1136/heartjnl-2020-318153
    

    >> Share

    
    
75. MARCUSCHAMER I, Zusman O, Iakobishvili Z, Assali AR, et al
    Outcome of patients with prior coronary bypass surgery admitted with an acute coronary syndrome.
    Heart. 2021 Jan 18. pii: heartjnl-2020-318047. doi: 10.1136/heartjnl-2020-318047
    

    >> Share

    
    
76. MAZNYCZKA AM, McCartney P, Duklas P, McEntegart M, et al
    Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial.
    Heart. 2021 Jan 12. pii: heartjnl-2020-317828. doi: 10.1136/heartjnl-2020-317828
    

    >> Share

    
    
77. VASCONCELOS M, Vasconcelos L, Ribeiro V, Campos C, et al
    Incidence and predictors of stroke in patients with rheumatic heart disease.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318054. doi: 10.1136/heartjnl-2020-318054.
    

    >> Share

    
    
78. WU J, Mamas MA, Mohamed MO, Kwok CS, et al
    Place and causes of acute cardiovascular mortality during the COVID-19 pandemic.
    Heart. 2021;107:113-119.
    

    >> Share

    
    
79. SINGH T, Newby DE
    Is the fear of disease worse than the disease itself?
    Heart. 2021;107:91-92.
    

    >> Share

    
    
80. OTTO CM
    Heartbeat: increased use of NOACs in patients with atrial fibrillation reduces health care system costs by reducing stroke incidence.
    Heart. 2021;107:1-3.
    

    >> Share

    
    December 2020
81. O' DONNELL M, Hankey GJ, Rangarajan S, Chin SL, et al
    Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level.
    Heart. 2020 Dec 14. pii: heartjnl-2019-316515. doi: 10.1136/heartjnl-2019-316515
    

    >> Share

    
    
82. GARCIA RODRIGUEZ LA, Cea Soriano L, Munk Hald S, Hallas J, et al
    Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke.
    Heart. 2020 Dec 11. pii: heartjnl-2020-317887. doi: 10.1136/heartjnl-2020-317887
    

    >> Share

    
    
83. HANON O, Vidal JS, Pisica-Donose G, Orvoen G, et al
    Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation.
    Heart. 2020 Dec 1. pii: heartjnl-2020-317923. doi: 10.1136/heartjnl-2020-317923.
    

    >> Share

    
    November 2020
84. SANJOY S, Choi YH, Holmes D, Herrman H, et al
    Comorbidity burden in patients undergoing left atrial appendage closure.
    Heart. 2020 Nov 23. pii: heartjnl-2020-317741. doi: 10.1136/heartjnl-2020-317741
    

    >> Share

    
    October 2020
85. SEIFFGE DJ, Meinel TR
    The real prize of direct oral anticoagulant blockbuster.
    Heart. 2020 Oct 28. pii: heartjnl-2020-318092. doi: 10.1136/heartjnl-2020-318092
    

    >> Share

    
    
86. ORLOWSKI A, Gale CP, Ashton R, Petrungaro B, et al
    Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation.
    Heart. 2020 Oct 28. pii: heartjnl-2020-317006. doi: 10.1136/heartjnl-2020-317006
    

    >> Share

    
    
87. BARRA S, Providencia R
    Anticoagulation in atrial fibrillation.
    Heart. 2020 Oct 28. pii: heartjnl-2020-316728. doi: 10.1136/heartjnl-2020-316728
    

    >> Share

    
    
88. BOYLE PM, Del Alamo JC, Akoum N
    Fibrosis, atrial fibrillation and stroke: clinical updates and emerging mechanistic models.
    Heart. 2020 Oct 23. pii: heartjnl-2020-317455. doi: 10.1136/heartjnl-2020-317455
    

    >> Share

    
    August 2020
89. HENDRIKS J, Gallagher C, Nyfort-Hansen K, Lau D, et al
    Adherence to anticoagulation therapy in patients with atrial fibrillation: is a tailored team-based approach warranted?
    Heart. 2020 Aug 7. pii: heartjnl-2020-317478. doi: 10.1136/heartjnl-2020-317478.
    

    >> Share

    
    May 2020
90. AL SAID S, Katus HA, Alabed S
    Cochrane corner: NOACs in atrial fibrillation patients post-percutaneous coronary intervention.
    Heart. 2020 May 29. pii: heartjnl-2020-316726. doi: 10.1136/heartjnl-2020-316726
    

    >> Share

    
    
91. BURDEN AF
    Tub bathing and heart disease.
    Heart. 2020;106:710.
    

    >> Share

    
    April 2020
92. SON MK, Park JJ, Lim NK, Kim WH, et al
    Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Heart. 2020 Apr 27. pii: heartjnl-2019-316219. doi: 10.1136/heartjnl-2019-316219
    

    >> Share

    
    
93. CHATEAUNEUF G, Nazif TM, Beaupre F, Kodali S, et al
    Cerebrovascular events after transcatheter mitral valve interventions: a systematic review and meta-analysis.
    Heart. 2020 Apr 17. pii: heartjnl-2019-316331. doi: 10.1136/heartjnl-2019-316331
    

    >> Share

    
    
94. OTTO CM
    Heartbeat: risk of stroke in patients with heart failure.
    Heart. 2020;106:549-551.
    

    >> Share

    
    March 2020
95. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    

    >> Share

    
    
96. UKAI T, Iso H, Yamagishi K, Saito I, et al
    Habitual tub bathing and risks of incident coronary heart disease and stroke.
    Heart. 2020 Mar 24. pii: heartjnl-2019-315752. doi: 10.1136/heartjnl-2019-315752
    

    >> Share

    
    
97. YAO X, Noseworthy P
    NOAC dosing and monitoring: really as simple as it seems?
    Heart. 2020;106:321-322.
    

    >> Share

    
    February 2020
98. KIM JY, Kim SH, Myong JP, Choi Y, et al
    Ten-year trends in the incidence, treatment and outcomes of patients with mitral stenosis in Korea.
    Heart. 2020 Feb 6. pii: heartjnl-2019-315883. doi: 10.1136/heartjnl-2019-315883.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share